E3

Three drugs, three biological hypotheses: Kardigan is putting precision cardiology to the test

RAS Has Finally Hit Pancreatic Cancer. Now Access Has to Catch Up.

Nighttime light was linked to heart remodelling. Cardiovascular prevention may need to look beyond diet and exercise

Same BMI, different biology: low-cost markers may expose the obesity risk the scale misses

Polycythemia Vera Gets a First-in-Class Option. Patients Need More Than Blood Draws.

Parkinson’s Risk Is Not One Thing

MRSA May Have A New Weakness

Cardiovascular AI is getting better. That does not mean it is getting fairer

Cardiometabolic risk leaves a protein signature in childhood. Could it guide prevention decades earlier?
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
